Drawing for WE MAKE CLINICAL TRIALS BORING

USPTO serial 97077265

WE MAKE CLINICAL TRIALS BORING

Reviewed by CopyMark Law Group

Reg. 6899821Status 700Registered
Filing date
Status date
Registration date
Nov 15, 2022
Examiner
KUNG, KAELIE ELIZABETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with WE MAKE CLINICAL TRIALS BORING?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Benjamin W. Janke

BENJAMIN W. JANKE BAKER, DONELSON, BEARMAN, CALDWELL & BERKOWITZ, A201 ST. CHARLES AVE., SUITE 3600NEW ORLEANS, LA 70170UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business consulting and management in the field of clinical trials, namely, providing information management services, supply chain monitoring, recordkeeping, workflows, data integrity validation, and data reportingACTIVEOct 2, 2020
042Software as a service (SAAS) featuring computer software platforms for use in database management in the field of clinical trials that enable automated, real-time inventory management, automated lab kit resupply, sample collection workflows, intelligent sample-to-lab routing, resupply for and chain of custody of clinical trial drugs, devices, and equipment, and access to stakeholders in the clinical trial ecosystem, namely, trial sponsors, contract research organizations, research sites, vendors, patients, and laboratories; consulting services for others in the field of design, planning, and implementation project management of clinical trialsACTIVEOct 2, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 15, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 15, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 30, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 30, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 10, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 27, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 21, 2022DOCKASSIGNED TO EXAMINER—
Nov 4, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance